Screening Libraries

Compound Library Advantages

  • Cost-effective and competitive price to save your findings.
  • Potent, selective and cell-permeable in inhibiting or activating target molecules.
  • Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.).
  • Detailed files describing potency, selectivity and applications etc.
  • Supported by published data from top peer-reviewed journals.
  • Guaranteed high quality with NMR and HPLC validation.

Bioactive Screening Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. They are available for high-throughput screening (HTS) and high-content screening (HCS).

 

• The libraries consist of over 2,500 small molecules with validated biological and pharmacological activities. The solubility, purity and stability of the compounds are also proved. Safety and effectiveness of the compounds has been demonstrated by literature, preclinical and clinical research, and many compounds are FDA-approved.

 

• The collections of unique small molecules, which include inhibitors, antagonists and agonists. These compounds focused on hundreds of targets that are part of more than 20 signaling pathways or research areas, which include DNA Damage/DNA Repair, Cell Cycle/Checkpoint, JAK/STAT Signaling Pathway, MAPK Signaling Pathway, GPCR/G protein, Angiogenesis, Immunology/Inflammation, Endocrinology and Hormones, Cancer Biology, Metabolism, Stem Cell, etc.

 

• We also provide customized bioactive screening libraries that allow you to choose the compounds, the sizes, the quantities, the format (powder or solution) and plate map you want in the library.

Library Name Catalogue Number Contents
Bioactive Compound Library Plus L1022P 4417 bioactive compounds
Anti-cancer Compound Library Plus L1023P 1777 anti-cancer compounds
Neuronal Signaling Compound Library Plus L1026P 948 neuronal signaling-related small molecules for neuroscience reasearch.
Anti-infection Compound Library Plus L1027P 663 anti-infection small molecules for anti-infection reasearch.
Ion Channel Compound Library Plus L1030P 350 ion channel-related compounds for high throughput screening (HTS) and high content screening (HCS).
Metabolism-related Compound Library Plus L1032P 1205 metabolism-related compounds for metabolism research.
Stem Cell Compound Library Plus L1040P 280 stem cell-related compounds for stem cell research.
Immunology/Inflammation Compound Library Plus L1042P 806 small molecule compounds for immunology/inflammation research.
NF-κB Signaling Compound Library Plus L1044P 178 NF-κB inhibitors for NF-κB signaling pathway research.
FDA-approved Drug Library L1021 FDA-approved drugs
Bioactive Compound Library L1022 3317 bioactive compounds
Anti-cancer Compound Library L1023 1164 anti-cancer compounds
Kinase Inhibitor Library L1024 796 kinase inhibitors for high throughput screening (HTS) and high content
GPCR Compound Library L1025 677 GPCR-related small molecules for GPCR screening.
Neuronal Signaling Library L1026 556 neuronal signaling-related small molecules for neuroscience reasearch
Anti-infection Compound Library L1027 367 anti-infection small molecules for anti-infection reasearch.
Tyrosine Kinase Inhibitor Library L1028 369 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).
Epigenetics Compound Library L1029 328 epigenetics-related small molecules for epigenetics reasearch.
Ion Channel Compound Library L1030 199 ion channel-related compounds for high throughput screening (HTS) and high content screening (HCS).
Autophagy Compound Library L1031 486 autophagy-related compounds for autophagy research.
Metabolism-related Library L1032 metabolism-related compounds for metabolism research.
DNA Damage/DNA Repair Library L1033 481 DNA Damage/DNA repair-related compounds for DNA damage/DNA repair research.
PI3K/Akt/mTOR Compound Library L1034 178 PI3K/Akt/mTOR inhibitors for PI3K/Akt/mTOR signaling pathway research.
Protease Inhibitor Library L1035 825 protease inhibitors for high throughput screening (HTS) and high content screening (HCS).
Apoptosis Compound Library L1036 643 apoptosis-related compounds for apoptosis research.
Cell Cycle Library L1037 449 cell cycle-related compounds for cell cycle research.
Histone Modification Library L1038 143 histone modification-related compounds for histone research.
Natural Product Library L1039 550 natural products for high throughput screening (HTS) and high content screening (HCS).
Stem Cell Compound Library L1040 169 stem cell-related compounds for stem cell research.
JAK/STAT Compound Library L1041 109 JAK/STAT inhibitors for JAK/STAT signaling pathway research.
Immunology/Inflammation Library L1042 295 small molecule compounds for immunology/inflammation research.
MAPK Inhibitor Library L1043 117 MAPK inhibitors for MAPK signaling pathway research.
NF-κB Signaling Library L1044 73 NF-κB inhibitors for NF-κB signaling pathway research.
TGF-beta/Smad Compound Library L1045 88 TGF-beta/Smad inhibitors for TGF-beta/Smad signaling pathway research.
Anti-diabetic Compound Library L1046 110 anti-diabetic small molecule compounds for diabetes research.
Angiogenesis Library L1047 84 small molecule compounds for angiogenesis research.
Inhibitor Library L1048 2525 inhibitors for high throughput screening (HTS) and high content screening (HCS).

Tech Contact

technical@stratech.co.uk

+44 1638 782600

General Contact

info@stratech.co.uk

+44 1638 782600

SUPPORT

outstanding technical support

PRODUCT

we offer a full product guarantee

DELIVERY

we offer free delivery to UK universities and non profit organisations